ࡱ> '` hUbjbjLULU .?.?4H\& > > > R OOO8OP\R p.&RR"RRPS3Z3Z3Z$h> Z{Y3ZZZ  RLPS+>eeeZ :S> PSeZee6 T> #PSR PfO\2_Wd4<p{ʝa"ʝ8#ʝ> #4 3ZGZeUZ aZS3Z3Z3Zd3Z3Z3ZpZZZZR d D"0R 0R R R     Module 6: Cancer Diagnosis and Staging Target Audience Community members Staff of Indian health programs, including Community Health Representatives Contents of Learning Module Instructors Guide with Pre/Post Self-Assessment PowerPoint presentation Glossary Resources for Learning More References Length Introduction of session/module overview (:05) Pre self-assessment (:07) Presentation of module (:30) Post self-assessment (:05) Closing (:03) Goals In this session, participants will gain an understanding of how cancer is diagnosed and how the extent or stage of cancer is determined. Objectives At the completion of Learning Module 6, participants will be able to demonstrate the following: Section 1 a) Describe what is meant by the term biopsy. b) Describe how tumors may behave differently from one another (e.g., well differentiated versus poorly differentiatied). Section 2 a) Give two examples of the stages of cancer and their meaning. b) Give two reasons why staging is important. Measures of Objective Accomplishment The presenter will administer a pre self-assessment and a post self-assessment to measure participants knowledge of the modules objectives. The pre self-assessment measures existing knowledge and the post self-assessment measures what was gained through the learning module.NOTE Each major learning point is clearly identified by boldface type throughout the guide and emphasized in the PowerPoint presentation. See the glossary (at the end of the module) for words that are in bold blue italics throughout the module. Pre/Post Self-Assessment Cancer Diagnosis and Staging Do you agree (A), disagree (D), with these statements, or are you not sure (NS)? Circle your choice - A, D, or NS. 1.ADNSA biopsy helps determine whether or not a tumor is benign (non-cancerous) or malignant (cancerous).2.ADNSMicroscopic examination of the tumor is an important part of a cancer diagnosis.3.ADNSCancer in situ is an early cancer that has not yet spread to neighboring tissue and has a very poor outcome.4.ADNSA cancer that is localized (has not spread to other areas of the body) has a good chance for control or cure.5.ADNSThe staging of cancer (determining the extent of disease) is an important part of determining treatment, disease outcome, and how the patient will respond to treatment. Pre/Post Self-Assessment Answer Key Cancer Diagnosis and Staging The correct answer to each question, agree (A), disagree (D), is underlined and in red. 1.ADA biopsy helps determine whether or not a tumor is benign (non-cancerous) or malignant (cancerous). Note: To diagnose the presence of cancer, a doctor must look at a biopsy sample of the affected tissue under a microscope.2.ADMicroscopic examination of the tumor is an important part of a cancer diagnosis. Note: Microscopic examination will help determine tumor grade, or how aggressive the cancer is and how fast it is growing.3.ADCancer in situ is an early cancer that has not yet spread to neighboring tissue and has a very poor outcome. Note: Cancer in situ is an early stage cancer with no invasion to surrounding tissue. It carries a very good prognosis for complete cure.4.ADA cancer that is localized (has not spread to other sites of the body) has a good chance for control or cure. Note: Localized cancers also have a good chance for control or cure.5.ADThe staging of cancer (determining the extent of disease) is an important part of determining treatment, disease outcome, and how the patient will respond to treatment. Note: Staging determines the extent of the disease, determines treatment, and helps determine a patients prognosis. Section 1   If you have a symptom, or your screening test result suggests cancer, the doctor must find out if it is due to cancer or some other cause. The doctor may ask about your personal and family medical history and do a physical exam. The doctor may also order lab tests, x-rays, or other tests or procedures. Tests of the blood, urine, or other fluids can show how well an organ is doing its job. Also, high amounts of substances called tumor markers may be a sign of cancer. However, doctors cannot rely on lab tests alone to diagnose cancer. Imaging procedures create pictures of areas inside your body that help the doctor see whether a tumor is present. These pictures can be made in several ways: X-rays: X-rays are the most common way to view organs and bones inside the body. CT scan: An x-ray machine linked to a computer takes a series of detailed pictures of your organs. You may receive a contrast material, such as a dye, to make these pictures easier to read. Radionuclide scan: You receive an injection of a small amount of radioactive material. It flows through your bloodstream and collects in certain bones or organs. A machine, called a scanner, detects and measure the radioactivity. The scanner creates pictures of bones or organs on a computer screen or on film. Your body gets rid of the radioactive substances quickly. Ultrasound: An ultrasound device sends out sound waves that people cannot hear. The waves bounce off tissues inside your body like an echo. A computer uses these echoes to create a picture called a sonogram. MRI: A strong magnet linked to a computer is used to make detailed pictures of areas in your body. Your doctor can view these pictures on a monitor and can print them on film. PET scan: You receive an injection of a small amount of radioactive material. A machine makes pictures that show chemical activities in the body. Cancer cells sometimes show up as areas of high activity.  To diagnose the presence of cancer, a doctor must look at a sample of the affected tissue under a microscope, also known as a biopsy. A biopsy is the surgical removal of a small piece of tissue for microscopic examination. Microscopic examination will tell the doctor whether a tumor is actually present and if so, whether it is malignant (cancerous) or benign (non-cancerous). There are three ways tissue can be removed for biopsy: endoscopy, needle biopsy, or surgical biopsy. Endoscopy By using a thin lighted tube, the doctor is able to look at areas inside the body and see whats going on, take pictures, and remove tissue or cells for examination, if necessary. Needle Biopsy The doctor takes a small tissue or fluid sample by inserting a needle into the abnormal (suspicious) area. Surgical Biopsy There are two types of surgical biopsies. An excisional biopsy is performed when the doctor removes the entire tumor, often with some surrounding normal tissue. An incisional biopsy is performed when the doctor removes just a portion of the tumor. If cancer is found to be present, the entire tumor may be removed immediately or during another operation. Once the doctor has removed the tumor and determined the presence of cancer, he will want to determine the aggressiveness of the cancer, or how fast the cancer is growing. To do this, the doctor will look at the tumor under the microscope to determine tumor grade, or how alike or different the cancer cells are from one another.  Under the microscope, some tumor cells look very much like the normal tissue they came from. If they do, they are called well differentiated. Cells in well differentiated tumors tend to grow and multiply slowly. Other tumors may only slightly resemble the normal tissue that they came from or they may not resemble any specific tissues. These tumor cells are called poorly differentiated or undifferentiated tumor cells. Generally speaking, tumors that are undifferentiated or poorly differentiated tend to be more aggressive in their behavior. They grow faster, spread earlier, and have poorer outcomes than well differentiated tumors. In summary, the biopsy has provided the doctor with the following important information: Whether or not the tumor is benign (non-cancerous) or malignant (cancer). The type of cancer (e.g., carcinoma versus sarcoma). See Module 2, Section 3: Types of Cancer. The aggressiveness or behavior of the tumor (e.g., well differentiated versus poorly differentiated). Section 2  Once the diagnosis of cancer has been made, the doctor will want to learn the stage, or extent, of the disease. This process is referred to as staging and tells the doctor how far the cancer in the original or primary tumor has spread in the body. Treatment decisions are based on the results of staging. The common stages of cancer are: In situ Early cancer that has not spread to neighboring tissue. It is present only in the layer of cells in which it began. Localized Cancer is found only in the organ where it started to grow. Regional Cancer has spread beyond the original or primary site to the surrounding tissues or lymph nodes. Distant Cancer has spread to other organs and systems of the body. Recurrent Cancer that has come back after a period of time during which it could not be found. The cancer may come back to the same place as the original tumor or to another place in the body. Unknown Cancer cases in which there is not enough information to indicate a stage. Staging is an important part of making a good diagnosis. Cancer in situ, cancer of an early stage with no invasion to surrounding tissue, carries a very good prognosis for complete cure. When cancer is more extensive (involving larger areas) but still has not spread to other sites, it is considered to be localized. Localized cancers also have a good chance for control or cure. Cancers that have begun to spread are classified according to the manner and extent of spread: by direct extension, by involvement of the lymph nodes, and by evidence of distant metastasis or spread. Though each type of cancer has its own progression of disease and the medical community has various methods of staging classification, staging can be generally described as follows: Stage 0 Carcinoma in situ. Early cancer that is present only in the layer of cells in which it began. Stage 1 A cancerous tumor is found to be limited to the organ of origin. Stage 2 The cancer has spread to the surrounding tissues and possibly to the local lymph nodes. Stage 3 There is extensive growth of the primary tumor and possible other organ involvement. Stage 4 The cancer has spread far into the other organs and systems of the body away from the original tumor site. Each cancer grows differently. The stage of cancer at the time of diagnosis means different things for different cancers. For example, lymph node involvement does not necessarily mean the same thing in every kind of cancer. Thus, the information about the extent of the cancer must be considered in light of the tissue diagnosis obtained from the biopsy. Staging is performed using a number of methods such as physical exams, imaging procedures (such as those described in Section 1, ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT or CAT scan), x- rays), laboratory tests (blood tests, urine sample, bone marrow biopsy), and even special surgery. In summary, the staging of cancer is important for three reasons: Staging determines the extent of the disease; Treatment is determined by the stage of the specific cancer; Staging helps determine the patients prognosis. Glossary of Terms biopsyThe surgical removal of a small piece of tissue for microscopic examination to check for cancer cells.bone marrow biopsyA procedure in which a needle is inserted into either the breast or pelvic bone to remove a small amount of liquid bone marrow (blood forming cells) for examination under a microscope. CT scan (computed tomography)An x-ray test using a computer to produce a detailed (CT or CAT scan) picture of a cross-section of the body. distant (cancer or metastasis)Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.endoscopyEndoscopy is a procedure that lets a doctor look inside a persons body. It uses an instrument called an endoscope, or scope for short. Scopes have a tiny camera attached to a long, thin lighted tube. The doctor moves it through a body passageway or opening to see inside an organ. Endoscopy can be used to take pictures, and remove tissue or cells for examination, if necessary.imaging proceduresSpecial tests that give detailed images of a persons body including x-rays, ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT or CAT scan).in situEarly cancer that has not spread to neighboring tissue.localizedWithin the site of origin, without evidence of spread.magnetic resonance imaging (MRI)A procedure in which radio waves and a powerful magnet linked to a computer is used to create detailed pictures of areas inside the body. These pictures show the difference between normal and diseased tissue.microscopic examinationUse of a microscope to visualize cells.needle biopsyType of biopsy by which the doctor inserts a needle into an abnormal (suspicious) area to remove a small tissue sample for diagnosis.poorly differentiated or undifferentiated tumor cellsTumor cells that may only slightly resemble the normal tissue that they came from; this type of tumor may tend to be more aggressive in their behavior, spread faster, and have a poorer outcome.recurrentCancer that has recurred (come back), usually after a period of time during which the cancer could not be detected. The cancer may come back to the same place as the original (primary) tumor or to another place in the body. Also called recurrence. regionalIn oncology, describes the body area right around a tumor.stagingDescribes how far the cancer has spread from the original site to other parts of the body (i.e. in situ, local, regional, or distant).surgical biopsyThere are two types of surgical biopsies. An excisional biopsy is performed when the doctor removes the entire tumor, often with some surrounding normal tissue. An incisional biopsy is performed when the doctor removes just a portion of the tumor.tumor gradeA description of a tumor based on how abnormal the cancer cells look under a microscope and how quickly the tumor is likely to grow and spread. Grading systems are different for each type of cancer.tumor markersA substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).ultrasoundAn exam in which sound waves are bounced off tissues and the echoes are converted into a picture.well differentiated tumor cellsCells that look and function similar to normal cells of the same type. Resources for Learning More Northwest Portland Area Indian Health Board Northwest Tribal Comprehensive Cancer Project: On this web page you can access the Northwest Tribal Cancer Resource Guide, full of resources for cancer survivors and caregivers. You can also access The Appointment Companion, a tool to help cancer survivors keep track of appointments and treatment.  HYPERLINK "http://www.npaihb.org/programs/project/nwtccp_reports_publications_media_materials/" http://www.npaihb.org/programs/project/nwtccp_reports_publications_media_materials/ National Cancer Institute (NCI) Cancer Information Summaries: Adult Treatment (PDQ): The Physician Data Query (PDQ) is NCIs comprehensive cancer database. It contains summaries on a wide range of cancer topics. This page links to an alphabetical list of PDQ adult cancer treatment summaries. These summaries provide site specific information on diagnosis and staging.  HYPERLINK "http://cancer.gov/cancertopics/pdq/adulttreatment" http://cancer.gov/cancertopics/pdq/adulttreatment NCI Fact Sheet: Cancer Staging: This fact sheet explains the process of grouping cancer cases in categories (stages) based on the size of the tumor and the extent of the cancer in the body.  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/Detection/staging" http://www.cancer.gov/cancertopics/factsheet/Detection/staging NCI Fact Sheet: Computed Tomography: A fact sheet that describes the CT scan procedure and technology and its uses in diagnosis and treatment.  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/detection/CT" http://www.cancer.gov/cancertopics/factsheet/detection/CT NCI Fact Sheet: Pathology Reports: A fact sheet that describes the type of information that may be found in a pathology report, the document that contains results of the visual and microscopic examination of tissue removed during a biopsy or surgery.  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/detection/pathology-reports" http://www.cancer.gov/cancertopics/factsheet/detection/pathology-reports NCI Fact Sheet: Tumor Grade: A fact sheet that discusses tumor grade and its role in prognosis. Explains concepts like normal cell biology and cell differentiation.  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/Detection/tumor-grade" http://www.cancer.gov/cancertopics/factsheet/Detection/tumor-grade NCI Fact Sheet: Tumor Markers: Questions and Answers: A fact sheet that explains tumor markers and answers questions about use in screening.  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers" http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers NCI Understanding Cancer Series: Cancer: This self-paced graphic-rich tutorial can be used for educational use by teachers, medical professionals, and the interested public. Can be downloaded in PDF and PowerPoint format.  HYPERLINK "http://www.cancer.gov/cancertopics/understandingcancer/cancer" http://www.cancer.gov/cancertopics/understandingcancer/cancer NCI - What You Need To Know AboutTM Cancer Index: A series of booklets on cancer. Each booklet explains possible risks, symptoms, diagnosis, and treatment and includes a list of questions to ask the doctor. Booklets are available for a number of different cancers.  HYPERLINK "http://www.cancer.gov/cancertopics/wyntk/" http://www.cancer.gov/cancertopics/wyntk/ References     CANCER 101: Version 2 (October 2011) Module 6 PAGE  PAGE 6 M6 -  National Cancer Institute (2006). Fact Sheet Tumor Markers. Available at:  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers" http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers  National Cancer Institute (2002). Fact Sheet Interpreting Laboratory Results. Available at:  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/detection/laboratory-tests" http://www.cancer.gov/cancertopics/factsheet/detection/laboratory-tests  National Cancer Institute (2004). Fact Sheet Tumor Grade. Available at:  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/detection/tumor-grade" http://www.cancer.gov/cancertopics/factsheet/detection/tumor-grade  National Cancer Institute (2010). Fact Sheet Cancer Staging. Available at:  HYPERLINK "http://www.cancer.gov/cancertopics/factsheet/Detection/staging" http://www.cancer.gov/cancertopics/factsheet/Detection/staging For more detailed information about cancer or the glossary terms, please refer to the Dictionary of Cancer Terms at  HYPERLINK "http://www.cancer.gov/" http://www.cancer.gov/ or call the National Cancer Institutes Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).  '()*+;MN饔yfVIVIfI9hhIm6CJ]^JaJhxs`hImCJ^JaJhxs`hIm6CJ]^JaJ$hxs`hIm56CJ\]^JaJ5hM9zhIm56B* CJ OJQJ\]^JaJ ph~!hM9zhImB*CJ ^JaJ ph)hM9zhIm56B* CJ \]aJ ph~1hyshIm5B* CJ0OJQJX\]aJ0ph~+hs5B* CJ0OJQJX\]aJ0ph~+hIm5B* CJ0OJQJX\]aJ0ph~()*+;N~oTE & Fx$Ifgd*B*^Jph%hM9zhIm56B* \]^Jph~hyshIm56\]^JhM9zhIm^JhsB*^JphhM9zhImB*^Jph!2 3 4 5 6 ; +  & F$IfgdEFI*$<$Ifa$gd*B*CJaJph&h5h55>*B*CJ\aJphh2h5B*ph"h2h55B*\ph"h5h556\]h2h556\]h556\]!h2h5B* CJ^JaJph~'h556B* CJ\]^JaJph~-h2h556B* CJ\]^JaJph~ h55CJOJQJX^JaJ&hh55CJOJQJX^JaJCNOVXY#$)+Hxs hk 6 hk hk hk h5h5>*B*CJaJph&h5h55>*B*CJ\aJphh2h5B*ph"h2h55B*\ph"h2h5^Jhk hk 6 hk 6\hk hk 56\hk hk 6\ hk 56h5 h?h5-$H:::/ <$Ifgd$$<$Ifa$gdJZkd$$Ifl      P\m$  0~~~~~~L622 s4 lap yt$$=///$<$Ifa$gdJZkd$$Ifl      3\m$  0~~~~~~L622 s4 lap yt$ <$Ifgd$=//$<$Ifa$gdJZkd $$Ifl      =\m$  0~~~~~~L622 s4 lap yt$ <$Ifgd$^_b/kd $$Ifl      \m$  0~~~~~~L622 s4 lap yt$ <$Ifgd$$<$Ifa$gdJZ]^_abcdefdeƻƻ񏊅}hT'h0hIm5>*B* CJ^JaJph~)hImhIm5B* OJQJX\]ph~h'=(h'=(6 h*B*CJaJph&h5h55>*B*CJ\aJphh2h5B*ph"h2h55B*\ph"h2h5^Jh:}kh:}k6 h:}k6 h:}k56h5h:}k h?h5bdf/kd $$Ifl      [\m$  0~~~~~~L622 s4 lap yt$ <$Ifgd$$<$Ifa$gdJZ[mi89= [!"gd gd gd  & F @ ^gd`U)gd`U) ]gd0gdIm$gdIm $a$gdIm%&%MZrsuvȱtb[M[F[M[ h  \^JjhPC0JU\^J h`U)\^J"hSh`U)56B* \^Jph~h  B*\^Jphh9mB*\^Jphh`U)B*\^JphhiB*\^Jphh05B*\^Jph-jh`U)5B*U\^JmHnHphuh0hImCJ0OJQJaJ0&j hCh`U)B* CJ0UaJ0ph~'h0hIm5>*B* CJ0^JaJ0ph~[cklm-.VW45ghir8:;<=۽۽ۯ۪ۣ h*B* CJ^JaJph~h%h@,M$If]Mgd>@kdr$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/666y8uf[ $Ifgd>@,M$If]Mgd>@kd#$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/y8z8829uf[ $Ifgdm,M$If]Mgdmkd԰$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/8889 9091939:9;9r9t9}9~99999ȷȷ쌪yhWJ:h56B* \]^Jph~hM9zhOJQJ^J!hM9zhB*OJQJ^Jph"!hM9zhB*OJQJ^Jph"%hM9zh56B* \]^Jph~h mB*OJQJ^Jph"h m56B* \]^Jph~hM9zhjOJQJ^J!h hMB*OJQJ^Jph"$h hMB*OJQJ]^Jph"!hdhMB*OJQJ^Jph"%hM9zhj56B* \]^Jph~2939;9s9uf[ $Ifgdm,M$If]Mgdmkd$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/s9t9~99uf[ $Ifgdm,M$If]Mgdmkd6$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/999:uf[ $Ifgdm,M$If]Mgdmkd$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/99a:b:::::::::::::;;;;x<y<z<۸zzi\K:Ki\!hM9zhjB*OJQJ^Jph"!hdhpB*OJQJ^Jph"hM9zhjOJQJ^J h/hjCJ OJQJ^JaJ hpB*OJQJ^Jph"%hM9zhj56B* \]^Jph~h56B* \]^Jph~hM9zh0 OJQJ^J)h/h/B*CJ OJQJ^JaJ ph"hB*OJQJ^Jph"!hM9zhB*OJQJ^Jph"%hM9zh0 56B* \]^Jph~::::uf[ $Ifgdm,M$If]Mgdmkd$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/:::;uf[ $Ifgdm,M$If]MgdmkdI$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/;;;y<uf[ $Ifgdm,M$If]Mgdmkd$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/y<z<<~=uf[ $Ifgdm,M$If]Mgdmkd$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/z<<~========R>T>c>d>>>>>??raTraFa2aF'hdhp5B*OJQJ\^Jph"hpB*OJQJ^Jph"hM9zhjOJQJ^J!hdhpB*OJQJ^Jph"%hM9zhj56B* \]^Jph~h56B* \]^Jph~hM9zhSOJQJ^J!hdhSB*OJQJ^Jph"hSB*OJQJ^Jph"hS56B* \]^Jph~hM9zhUOJQJ^J!hUhUB*OJQJ^Jph"hU56B* \]^Jph~~====uf[ $Ifgdm,M$If]Mgdmkd\$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/===S>uf[ $Ifgdm,M$If]Mgdmkd $$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/S>T>d>^?uf[ $Ifgdm,M$If]Mgdmkd$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/? ??]?_?k?2@3@@@A@@@AAAAA7B8B9BXBYBBBɹtfUɇt@ɇt)h/h/B*CJ OJQJ^JaJ ph"!h3hjB*OJQJ^Jph"h3B*OJQJ^Jph"%hM9zhj56B* \]^Jph~h56B* \]^Jph~!hM9zh3B*OJQJ^Jph"!h3h3B*OJQJ^Jph"h356B* \]^Jph~!hM9zhjB*OJQJ^Jph"'hdhp5B*OJQJ\^Jph"!hdhpB*OJQJ^Jph"^?_?k?2@uf[ $Ifgdm,M$If]Mgdmkdo$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/2@3@A@Auf[ $Ifgdm,M$If]Mgdmkd $$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/AAA8Buf[ $Ifgdm,M$If]Mgdmkdѹ$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/8B9BYBBuf[ $Ifgdm,M$If]Mgdmkd$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/BBBBDDPFFFH3Iupe`````YYgd_-gd_- $$oa$gd_-gdjkd3$$Ifl      0P `'  t0~~~~~~'2s2h44 lagfyt/ BBBBCDD&DyD{D|D}DDDDDD#E(E)E*E+E-EJEKEEEEOFPFQF]FFFҸʯåyumuiauZu h9;dh9;djh9;dUh_-h!h9;dH*h9;dh!h!H*h!hx~hx~hx~56hx~h_-56H* h9;d56hx~h_-56hhum~0J"jhum~U hum~hum~jhum~Uhum~ hum~56 h_-5CJOJQJX^JaJhjjhw+UmHnHu!FFFFFFFFFFGGGGGGGGHHHH@HBHHHHHHHHH0I1I2I3IXIZI1J3J4J@JJJJJJJJJJJ߻ƴjh UhP@PdPnPoPpPqPrP糟{f{_[QjhT@TATTTTھrc_QFQhw+5OJQJ^Jh\ohw+5OJQJ^Jhr[hPCh 0J"OJQJ^J'jhPCh OJQJU^J!jhPCh OJQJU^JhPCh OJQJ^J%jhPCh 0JOJQJU^J h h h h OJQJ^Jh h 0J"OJQJ^J!jh h OJQJU^J'jh h OJQJU^JTTTTTTTTT^U_U`UbUcUdUeUfUgUhU߮ߪs&hh;h5CJOJQJX^JaJhELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmAdobedC ##''$ %'% $('++++'()02520)7;;;;7;;;;;;;;;;;;;;;C ""2(!(2;2222;;;;;;;;;;;;;;;;;@@@@@;@@@@@@@@@@@@@@@@@@@@@a" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?Z( ( dCOVCBfv'QEEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEjpf-1Dtc_ӵiJ;GJ˙Q ꗖi;*U. vgVCEJN|BҷCk \-.q+z?LU{79$xу:+ElڶBw'?Pԭe8=nZ<0اY(2QYAEPE XҿE?=Jm%vgx弴Lo//>sڵ!mQF{ "ԼC9X(%c`UQȧ}\Ѿrw0cݹWSx,u.^ Z):usnO=O+٘~s]LF 8*r**QnkNɦZ%ֶG֝XĶ7.[j& #UB2؊!mb8ү$| zzsƱHpyn4f2v1˖r: ?-Ԛ";҄$ytVvG}oh4F⤶ (A\9فA0,˟}AӹA.nyqMh~gx'O5?rd2vv_nn`Al*<+~9 q#|eHfT˹؅܀[ צA5>v4jrJT}gj~&aSUDm;s=v[Dw L殹[ukcxܠ,O$pyPN9"(5Q,-JUyb<7?.9=9_.*(@)Eng_>0 wn'guz$y8i|JDjV<]kEz!Ubb1Î1biM)+3ε-6RLe/'iP9"ZUYYT363ܡ@zl\Gy@X`\x^΄%dq0c<=Td+=$yu)ic.)0HYqw]@~^㚠 4Fl}bζ' \7$ހVEPBX|YYIΛKk&㑻@;K^;ܴq d`"%jNn=l̚mŢ]kh[]\iՊ|Kmcq8B嶢`0 <8?T#)^݈RQ-*BJ7|w:l9kT~OݯxQHc++c a!#*qI*c(BNmEghzzѿ֍sJ..a8*K`)jӟ] ( r̹W;p+k@FmOqi6zt3Z#ӫ5O-bQ7)f&f1L[BzVD_G_SA,CqS;T93cwRN_m*H= \)IկZ5 A鄓Xǯֹ jZ$ 秿]`$6?mhg4丸}2Yvb۸oo~ե){Kc M5*zJ!|S|N3N<տ V9vQq>(j#End.:%y9-qH«(jp'~HsT҉4-6pOq 1Tw9 MMʂNHãu-s%<#Qq+WGof=rxy)ȷ^ LJ=B{~T70ܑܒ*8tBytWGW>tek~{׺HY8xo_M%Kdlك6|gjW#*鱙Iۃq8O\OD,mUUv G$wn Ui*Jt7_fSQu9_H+/ 냼78N87odG}>\^j땻Vo(7G㑐xir-"*\ir,lDW*I۸.ssЌ0F5cEQ\Ǣ^-F#A8V(ҒެEr6=HEYQHaEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEjpf-1Dtc_ӵiJ;GJ˙Q ꗖi;*U. vgVCEJN|BҷCk \-.q+z?LU{79$xу:+ElڶBw'?Pԭe8=nZ<0اY(2QYAEPE XҿE?=Jm%vgx弴Lo//>sڵ!mQF{ "ԼC9X(%c`UQȧ}\Ѿrw0cݹWSx,u.^ Z):usnO=O+٘~s]LF 8*r**QnkNɦZ%ֶG֝XĶ7.[j& #UB2؊!mb8ү$| zzsƱHpyn4f2v1˖r: ?-Ԛ";҄$ytVvG}oh4F⤶ (A\9فA0,˟}AӹA.nyqMh~gx'O5?rd2vv_nn`Al*<+~9 q#|eHfT˹؅܀[ צA5>v4jrJT}gj~&aSUDm;s=v[Dw L殹[ukcxܠ,O$pyPN9"(5Q,-JUyb<7?.9=9_.*(@)Eng_>0 wn'guz$y8i|JDjV<]kEz!Ubb1Î1biM)+3ε-6RLe/'iP9"ZUYYT363ܡ@zl\Gy@X`\x^΄%dq0c<=Td+=$yu)ic.)0HYqw]@~^㚠 4Fl}bζ' \7$ހVEPBX|YYIΛKk&㑻@;K^;ܴq d`"%jNn=l̚mŢ]kh[]\iՊ|Kmcq8B嶢`0 <8?T#)^݈RQ-*BJ7|w:l9kT~OݯxQHc++c a!#*qI*c(BNmEghzzѿ֍sJ..a8*K`)jӟ] ( r̹W;p+k@FmOqi6zt3Z#ӫ5O-bQ7)f&f1L[BzVD_G_SA,CqS;T93cwRN_m*H= \)IկZ5 A鄓Xǯֹ jZ$ 秿]`$6?mhg4丸}2Yvb۸oo~ե){Kc M5*zJ!|S|N3N<տ V9vQq>(j#End.:%y9-qH«(jp'~HsT҉4-6pOq 1Tw9 MMʂNHãu-s%<#Qq+WGof=rxy)ȷ^ LJ=B{~T70ܑܒ*8tBytWGW>tek~{׺HY8xo_M%Kdlك6|gjW#*鱙Iۃq8O\OD,mUUv G$wn Ui*Jt7_fSQu9_H+/ 냼78N87odG}>\^j땻Vo(7G㑐xir-"*\ir,lDW*I۸.ssЌ0F5cEQ\Ǣ^-F#A8V(ҒެEr6=HEYQHaEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEjpf-1Dtc_ӵiJ;GJ˙Q ꗖi;*U. vgVCEJN|BҷCk \-.q+z?LU{79$xу:+ElڶBw'?Pԭe8=nZ<0اY(2QYAEPE XҿE?=Jm%vgx弴Lo//>sڵ!mQF{ "ԼC9X(%c`UQȧ}\Ѿrw0cݹWSx,u.^ Z):usnO=O+٘~s]LF 8*r**QnkNɦZ%ֶG֝XĶ7.[j& #UB2؊!mb8ү$| zzsƱHpyn4f2v1˖r: ?-Ԛ";҄$ytVvG}oh4F⤶ (A\9فA0,˟}AӹA.nyqMh~gx'O5?rd2vv_nn`Al*<+~9 q#|eHfT˹؅܀[ צA5>v4jrJT}gj~&aSUDm;s=v[Dw L殹[ukcxܠ,O$pyPN9"(5Q,-JUyb<7?.9=9_.*(@)Eng_>0 wn'guz$y8i|JDjV<]kEz!Ubb1Î1biM)+3ε-6RLe/'iP9"ZUYYT363ܡ@zl\Gy@X`\x^΄%dq0c<=Td+=$yu)ic.)0HYqw]@~^㚠 4Fl}bζ' \7$ހVEPBX|YYIΛKk&㑻@;K^;ܴq d`"%jNn=l̚mŢ]kh[]\iՊ|Kmcq8B嶢`0 <8?T#)^݈RQ-*BJ7|w:l9kT~OݯxQHc++c a!#*qI*c(BNmEghzzѿ֍sJ..a8*K`)jӟ] ( r̹W;p+k@FmOqi6zt3Z#ӫ5O-bQ7)f&f1L[BzVD_G_SA,CqS;T93cwRN_m*H= \)IկZ5 A鄓Xǯֹ jZ$ 秿]`$6?mhg4丸}2Yvb۸oo~ե){Kc M5*zJ!|S|N3N<տ V9vQq>(j#End.:%y9-qH«(jp'~HsT҉4-6pOq 1Tw9 MMʂNHãu-s%<#Qq+WGof=rxy)ȷ^ LJ=B{~T70ܑܒ*8tBytWGW>tek~{׺HY8xo_M%Kdlك6|gjW#*鱙Iۃq8O\OD,mUUv G$wn Ui*Jt7_fSQu9_H+/ 냼78N87odG}>\^j땻Vo(7G㑐xir-"*\ir,lDW*I۸.ssЌ0F5cEQ\Ǣ^-F#A8V(ҒެEr6=HEYQHaEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEjpf-1Dtc_ӵiJ;GJ˙Q ꗖi;*U. vgVCEJN|BҷCk \-.q+z?LU{79$xу:+ElڶBw'?Pԭe8=nZ<0اY(2QYAEPE XҿE?=Jm%vgx弴Lo//>sڵ!mQF{ "ԼC9X(%c`UQȧ}\Ѿrw0cݹWSx,u.^ Z):usnO=O+٘~s]LF 8*r**QnkNɦZ%ֶG֝XĶ7.[j& #UB2؊!mb8ү$| zzsƱHpyn4f2v1˖r: ?-Ԛ";҄$ytVvG}oh4F⤶ (A\9فA0,˟}AӹA.nyqMh~gx'O5?rd2vv_nn`Al*<+~9 q#|eHfT˹؅܀[ צA5>v4jrJT}gj~&aSUDm;s=v[Dw L殹[ukcxܠ,O$pyPN9"(5Q,-JUyb<7?.9=9_.*(@)Eng_>0 wn'guz$y8i|JDjV<]kEz!Ubb1Î1biM)+3ε-6RLe/'iP9"ZUYYT363ܡ@zl\Gy@X`\x^΄%dq0c<=Td+=$yu)ic.)0HYqw]@~^㚠 4Fl}bζ' \7$ހVEPBX|YYIΛKk&㑻@;K^;ܴq d`"%jNn=l̚mŢ]kh[]\iՊ|Kmcq8B嶢`0 <8?T#)^݈RQ-*BJ7|w:l9kT~OݯxQHc++c a!#*qI*c(BNmEghzzѿ֍sJ..a8*K`)jӟ] ( r̹W;p+k@FmOqi6zt3Z#ӫ5O-bQ7)f&f1L[BzVD_G_SA,CqS;T93cwRN_m*H= \)IկZ5 A鄓Xǯֹ jZ$ 秿]`$6?mhg4丸}2Yvb۸oo~ե){Kc M5*zJ!|S|N3N<տ V9vQq>(j#End.:%y9-qH«(jp'~HsT҉4-6pOq 1Tw9 MMʂNHãu-s%<#Qq+WGof=rxy)ȷ^ LJ=B{~T70ܑܒ*8tBytWGW>tek~{׺HY8xo_M%Kdlك6|gjW#*鱙Iۃq8O\OD,mUUv G$wn Ui*Jt7_fSQu9_H+/ 냼78N87odG}>\^j땻Vo(7G㑐xir-"*\ir,lDW*I۸.ssЌ0F5cEQ\Ǣ^-F#A8V(ҒެEr6=HEYQHaEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEjpf-1Dtc_ӵiJ;GJ˙Q ꗖi;*U. vgVCEJN|BҷCk \-.q+z?LU{79$xу:+ElڶBw'?Pԭe8=nZ<0اY(2QYAEPE XҿE?=Jm%vgx弴Lo//>sڵ!mQF{ "ԼC9X(%c`UQȧ}\Ѿrw0cݹWSx,u.^ Z):usnO=O+٘~s]LF 8*r**QnkNɦZ%ֶG֝XĶ7.[j& #UB2؊!mb8ү$| zzsƱHpyn4f2v1˖r: ?-Ԛ";҄$ytVvG}oh4F⤶ (A\9فA0,˟}AӹA.nyqMh~gx'O5?rd2vv_nn`Al*<+~9 q#|eHfT˹؅܀[ צA5>v4jrJT}gj~&aSUDm;s=v[Dw L殹[ukcxܠ,O$pyPN9"(5Q,-JUyb<7?.9=9_.*(@)Eng_>0 wn'guz$y8i|JDjV<]kEz!Ubb1Î1biM)+3ε-6RLe/'iP9"ZUYYT363ܡ@zl\Gy@X`\x^΄%dq0c<=Td+=$yu)ic.)0HYqw]@~^㚠 4Fl}bζ' \7$ހVEPBX|YYIΛKk&㑻@;K^;ܴq d`"%jNn=l̚mŢ]kh[]\iՊ|Kmcq8B嶢`0 <8?T#)^݈RQ-*BJ7|w:l9kT~OݯxQHc++c a!#*qI*c(BNmEghzzѿ֍sJ..a8*K`)jӟ] ( r̹W;p+k@FmOqi6zt3Z#ӫ5O-bQ7)f&f1L[BzVD_G_SA,CqS;T93cwRN_m*H= \)IկZ5 A鄓Xǯֹ jZ$ 秿]`$6?mhg4丸}2Yvb۸oo~ե){Kc M5*zJ!|S|N3N<տ V9vQq>(j#End.:%y9-qH«(jp'~HsT҉4-6pOq 1Tw9 MMʂNHãu-s%<#Qq+WGof=rxy)ȷ^ LJ=B{~T70ܑܒ*8tBytWGW>tek~{׺HY8xo_M%Kdlك6|gjW#*鱙Iۃq8O\OD,mUUv G$wn Ui*Jt7_fSQu9_H+/ 냼78N87odG}>\^j땻Vo(7G㑐xir-"*\ir,lDW*I۸.ssЌ0F5cEQ\Ǣ^-F#A8V(ҒެEr6=HEYQHaEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEPQVCBƭ­ҡEVfEPEPEPEjpf-1Dtc_ӵiJ;GJ˙Q ꗖi;*U. vgVCEJN|BҷCk \-.q+z?LU{79$xу:+ElڶBw'?Pԭe8=nZ<0اY(2QYAEPE XҿE?=Jm%vgx弴Lo//>sڵ!mQF{ "ԼC9X(%c`UQȧ}\Ѿrw0cݹWSx,u.^ Z):usnO=O+٘~s]LF 8*r**QnkNɦZ%ֶG֝XĶ7.[j& #UB2؊!mb8ү$| zzsƱHpyn4f2v1˖r: ?-Ԛ";҄$ytVvG}oh4F⤶ (A\9فA0,˟}AӹA.nyqMh~gx'O5?rd2vv_nn`Al*<+~9 q#|eHfT˹؅܀[ צA5>v4jrJT}gj~&aSUDm;s=v[Dw L殹[ukcxܠ,O$pyPN9"(5Q,-JUyb<7?.9=9_.*(@)Eng_>0 wn'guz$y8i|JDjV<]kEz!Ubb1Î1biM)+3ε-6RLe/'iP9"ZUYYT363ܡ@zl\Gy@X`\x^΄%dq0c<=Td+=$yu)ic.)0HYqw]@~^㚠 4Fl}bζ' \7$ހVEPBX|YYIΛKk&㑻@;KELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmAdobedC ##''$ %'% $('++++'()02520)7;;;;7;;;;;;;;;;;;;;;C ""2(!(2;2222;;;;;;;;;;;;;;;;;@@@@@;@@@@@@@@@@@@@@@@@@@@@a" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?Z( ( m5%G?5nn֕ (5 ( ( ( ( m5%G?5nn֕ (5 ( ( ( ( m5%G?5nn֕ (5 ( ( ( ( m5%G?5nn֕ (5 ( ( ( ( m5%G?5nn֕ (5 ( ( ( ( m5%G?5nn֕ (5 ( ( ( kv[’2 @չ[tgc>¸<7qf{[㷷x1(FZؚ!hW;HfK NE$k,֧˜9۔nF?JVCEZj YE+5jݬ*/o", ?K CީSW"us^Bs.H韽t 3%\qƺPmJ;e8#ӂWXjdjGQEbuQ@U=[SM"ݥnq\$=۲{~&2I_0?nób zc1ڸ#yfO,`2oXx1t(}NJ<ǝԜi^4ki[l7)"gVC^{xxu8YJP~+ա=Tp9g5iJW4biթ;uJ[JAw5%s:[SgQWT)W—/7sЫiڡE*c=%AOI#Ұڮ7rHIzpvVn>ʫUJ"F8h)+մMvV/55hRF\󋋳;TH *K K %~Yd VbHO ^$w?ZT:GWg$|*`ۈBMj⵼leX쭒znSCW}!ѸS쁐*k  }dU0o^`?+H*N.5&5.}emK^! ӑǥpZeߕ28g_wK-w.du~ \mpg >zpGZFSiƤ)FM[5(˱%3`9lRŷn@v񑟻Nt+IHfp8sW[Gg0T`W) Yӥ:-.!C~dzElcdQE!Q@Q@ι}X0s^ '||{]G?VW.6c~m֮'Yu*L߉?J֭ں3P5cP`N=((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P(((:iY)# ` [eFv8 +w&g! n;{wc~҄e͉R5y3dPTROM2 jq,ÝO۸gm4U՝a_2ZXƭ¬+x`İ?}>y%r'_:Hu;) g=䎙OzЮ:XHpGkѵԭð *S=qJ8%xVOy^EV'PQEQESյ4-V2OoښM!JJ)k$٫H;qܞ:{;6.m۷;c7˙Fd=A~:S&]J]?*t鴣yѯ]Iٶn#F6΃q8žO+fm5纗/QŔ =һk-Z^ݞ3N7 qSVsL6&Z[~IuĤ]p#Q2[w8uU?{u*QqB{^)rw= ƝR;؏T0񞄒=+ <=|G$4׮oOAfX-DiӆB"[J4ގmEbsZQVu+,`nm|>=q[U83Hԏ2 (NԿ2[i~kOŚiLPf!/NJb@87sX>H_9jmUCuF}bAlg" A8ﶪ+[U8ُ)}'pe eA,#LןT6OݏdS\{1zvQ4b=BFL~c_<9P1w<@w895ICK*{-f(f!>].+[QAS:,U k{#Sl|?S~xz~F>ƪI_N(N2QQIߎ8۟ן־!:Am1ob7>?O54)p]C0Ȯ#S<'(bS8lc pOM'Ecszb^>1hVL'zvsyr( pȬ aQ= tB1qv8kTf-h_Ord# \ j֋KF^)IݼJ[l͑'#k3o/o5wKּg! `IX{v.Q5&oWm'/F\㞙py?](Kray؜8ہ0=-V CaGw+7O⢗TQq6]~R;@G|rW(;sU!jMǺ!?cN:f<3cfMVy!JB8_Y03*1A`O8`t4:-.!C~dz4dP3M;_v4QErS]E*F4(G_·>^rꇷ><¸<7qf{[㷷x1(FZؚ!hW;HfK NE$k,֧˜9۔nF?JVCEZj YE+5jݬ*/o", ?K CީSW"us^Bs.H韽t 3%\qƺPmJ;e8#ӂWXjdjGQEbuQ@U=[SM"ݥnq\$=۲{~&2I_0?nób zc1ڸ#yfO,`2oXx1t(}NJ<ǝԜi^4ki[l7)"gVC^{xxu8YJP~+ա=Tp9g5iJW4biթ;uJ[JAw5%s:[SgQWT)W—/7sЫiڡE*c=%AOI#Ұڮ7rHIzpvVn>ʫUJ"F8h)+մMvV/55hRF\󋋳;TH *K K %~Yd VbHO ^$w?ZT:GWg$|*`ۈBMj⵼leX쭒znSCW}!ѸS쁐*k  }dU0o^`?+H*N.5&5.}emK^! ӑǥpZeߕ28g_wK-w.du~ \mpg >zpGZFSiƤ)FM[5(˱%3`9lRŷn@v񑟻Nt+IHfp8sW[Gg0T`W) Yӥ:-.!C~dzElcdQE!Q@Q@ι}X0s^ '||{]G?VW.6c~m֮'Yu*L߉?J֭ں3P5cP`N=((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P(((:iY)# ` [eFv8 +w&g! n;{wc~҄e͉R5y3dPTROM2 jq,ÝO۸gm4U՝a_2ZXƭ¬+x`İ?}>y%r'_:Hu;) g=䎙OzЮ:XHpGkѵԭð *S=qJ8%xVOy^EV'PQEQESյ4-V2OoښM!JJ)k$٫H;qܞ:{;6.m۷;c7˙Fd=A~:S&]J]?*t鴣yѯ]Iٶn#F6΃q8žO+fm5纗/QŔ =һk-Z^ݞ3N7 qSVsL6&Z[~IuĤ]p#Q2[w8uU?{u*QqB{^)rw= ƝR;؏T0񞄒=+ <=|G$4׮oOAfX-DiӆB"[J4ގmEbsZQVu+,`nm|>=q[U83Hԏ2 (NԿ2[i~kOŚiLPf!/NJb@87sX>H_9jmUCuF}bAlg" A8ﶪ+[U8ُ)}'pe eA,#LןT6OݏdS\{1zvQ4b=BFL~c_<9P1w<@w895ICK*{-f(f!>].+[QAS:,U k{#Sl|?S~xz~F>ƪI_N(N2QQIߎ8۟ן־!:Am1ob7>?O54)p]C0Ȯ#S<'(bS8lc pOM'Ecszb^>1hVL'zvsyr( pȬ aQ= tB1qv8kTf-h_Ord# \ j֋KF^)IݼJ[l͑'#k3o/o5wKּg! `IX{v.Q5&oWm'/F\㞙py?](Kray؜8ہ0=-V CaGw+7O⢗TQq6]~R;@G|rW(;sU!jMǺ!?cN:f<3cfMVy!JB8_Y03*1A`O8`t4:-.!C~dz4dP3M;_v4QErS]E*F4(G_·>^rꇷ><¸<7qf{[㷷x1(FZؚ!hW;HfK NE$k,֧˜9۔nF?JVCEZj YE+5jݬ*/o", ?K CީSW"us^Bs.H韽t 3%\qƺPmJ;e8#ӂWXjdjGQEbuQ@U=[SM"ݥnq\$=۲{~&2I_0?nób zc1ڸ#yfO,`2oXx1t(}NJ<ǝԜi^4ki[l7)"gVC^{xxu8YJP~+ա=Tp9g5iJW4biթ;uJ[JAw5%s:[SgQWT)W—/7sЫiڡE*c=%AOI#Ұڮ7rHIzpvVn>ʫUJ"F8h)+մMvV/55hRF\󋋳;TH *K K %~Yd VbHO ^$w?ZT:GWg$|*`ۈBMj⵼leX쭒znSCW}!ѸS쁐*k  }dU0o^`?+H*N.5&5.}emK^! ӑǥpZeߕ28g_wK-w.du~ \mpg >zpGZFSiƤ)FM[5(˱%3`9lRŷn@v񑟻Nt+IHfp8sW[Gg0T`W) Yӥ:-.!C~dzElcdQE!Q@Q@ι}X0s^ '||{]G?VW.6c~m֮'Yu*L߉?J֭ں3P5cP`N=((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P(((:iY)# ` [eFv8 +w&g! n;{wc~҄e͉R5y3dPTROM2 jq,ÝO۸gm4U՝a_2ZXƭ¬+x`İ?}>y%r'_:Hu;) g=䎙OzЮ:XHpGkѵԭð *S=qJ8%xVOy^EV'PQEQESյ4-V2OoښM!JJ)k$٫H;qܞ:{;6.m۷;c7˙Fd=A~:S&]J]?*t鴣yѯ]Iٶn#F6΃q8žO+fm5纗/QŔ =һk-Z^ݞ3N7 qSVsL6&Z[~IuĤ]p#Q2[w8uU?{u*QqB{^)rw= ƝR;؏T0񞄒=+ <=|G$4׮oOAfX-DiӆB"[J4ގmEbsZQVu+,`nm|>=q[U83Hԏ2 (NԿ2[i~kOŚiLPf!/NJb@87sX>H_9jmUCuF}bAlg" A8ﶪ+[U8ُ)}'pe eA,#LןT6OݏdS\{1zvQ4b=BFL~c_<9P1w<@w895ICK*{-f(f!>].+[QAS:,U k{#Sl|?S~xz~F>ƪI_N(N2QQIߎ8۟ן־!:Am1ob7>?O54)p]C0Ȯ#S<'(bS8lc pOM'Ecszb^>1hVL'zvsyr( pȬ aQ= tB1qv8kTf-h_Ord# \ j֋KF^)IݼJ[l͑'#k3o/o5wKּg! `IX{v.Q5&oWm'/F\㞙py?](Kray؜8ہ0=-V CaGw+7O⢗TQq6]~R;@G|rW(;sU!jMǺ!?cN:f<3cfMVy!JB8_Y03*1A`O8`t4:-.!C~dz4dP3M;_v4QErS]E*F4(G_·>^rꇷ><¸<7qf{[㷷x1(FZؚ!hW;HfK NE$k,֧˜9۔nF?JVCEZj YE+5jݬ*/o", ?K CީSW"us^Bs.H韽t 3%\qƺPmJ;e8#ӂWXjdjGQEbuQ@U=[SM"ݥnq\$=۲{~&2I_0?nób zc1ڸ#yfO,`2oXx1t(}NJ<ǝԜi^4ki[l7)"gVC^{xxu8YJP~+ա=Tp9g5iJW4biթ;uJ[JAw5%s:[SgQWT)W—/7sЫiڡE*c=%AOI#Ұڮ7rHIzpvVn>ʫUJ"F8h)+մMvV/55hRF\󋋳;TH *K K %~Yd VbHO ^$w?ZT:GWg$|*`ۈBMj⵼leX쭒znSCW}!ѸS쁐*k  }dU0o^`?+H*N.5&5.}emK^! ӑǥpZeߕ28g_wK-w.du~ \mpg >zpGZFSiƤ)FM[5(˱%3`9lRŷn@v񑟻Nt+IHfp8sW[Gg0T`W) Yӥ:-.!C~dzElcdQE!Q@Q@ι}X0s^ '||{]G?VW.6c~m֮'Yu*L߉?J֭ں3P5cP`N=((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P(((:iY)# ` [eFv8 +w&g! n;{wc~҄e͉R5y3dPTROM2 jq,ÝO۸gm4U՝a_2ZXƭ¬+x`İ?}>y%r'_:Hu;) g=䎙OzЮ:XHpGkѵԭð *S=qJ8%xVOy^EV'PQEQESյ4-V2OoښM!JJ)k$٫H;qܞ:{;6.m۷;c7˙Fd=A~:S&]J]?*t鴣yѯ]Iٶn#F6΃q8žO+fm5纗/QŔ =һk-Z^ݞ3N7 qSVsL6&Z[~IuĤ]p#Q2[w8uU?{u*QqB{^)rw= ƝR;؏T0񞄒=+ <=|G$4׮oOAfX-DiӆB"[J4ގmEbsZQVu+,`nm|>=q[U83Hԏ2 (NԿ2[i~kOŚiLPf!/NJb@87sX>H_9jmUCuF}bAlg" A8ﶪ+[U8ُ)}'pe eA,#LןT6OݏdS\{1zvQ4b=BFL~c_<9P1w<@w895ICK*{-f(f!>].+[QAS:,U k{#Sl|?S~xz~F>ƪI_N(N2QQIߎ8۟ן־!:Am1ob7>?O54)p]C0Ȯ#S<'(bS8lc pOM'Ecszb^>1hVL'zvsyr( pȬ aQ= tB1qv8kTf-h_Ord# \ j֋KF^)IݼJ[l͑'#k3o/o5wKּg! `IX{v.Q5&oWm'/F\㞙py?](Kray؜8ہ0=-V CaGw+7O⢗TQq6]~R;@G|rW(;sU!jMǺ!?cN:f<3cfMVy!JB8_Y03*1A`O8`t4:-.!C~dz4dP3M;_v4QErS]E*F4(G_·>^rꇷ><¸<7qf{[㷷x1(FZؚ!hW;HfK NE$k,֧˜9۔nF?JVCEZj YE+5jݬ*/o", ?K CީSW"us^Bs.H韽t 3%\qƺPmJ;e8#ӂWXjdjGQEbuQ@U=[SM"ݥnq\$=۲{~&2I_0?nób zc1ڸ#yfO,`2oXx1t(}NJ<ǝԜi^4ki[l7)"gVC^{xxu8YJP~+ա=Tp9g5iJW4biթ;uJ[JAw5%s:[SgQWT)W—/7sЫiڡE*c=%AOI#Ұڮ7rHIzpvVn>ʫUJ"F8h)+մMvV/55hRF\󋋳;TH *K K %~Yd VbHO ^$w?ZT:GWg$|*`ۈBMj⵼leX쭒znSCW}!ѸS쁐*k  }dU0o^`?+H*N.5&5.}emK^! ӑǥpZeߕ28g_wK-w.du~ \mpg >zpGZFSiƤ)FM[5(˱%3`9lRŷn@v񑟻Nt+IHfp8sW[Gg0T`W) Yӥ:-.!C~dzElcdQE!Q@Q@ι}X0s^ '||{]G?VW.6c~m֮'Yu*L߉?J֭ں3P5cP`N=((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P(((:iY)# ` [eFv8 +w&g! n;{wc~҄e͉R5y3dPTROM2 jq,ÝO۸gm4U՝a_2ZXƭ¬+x`İ?}>y%r'_:Hu;) g=䎙OzЮ:XHpGkѵԭð *S=qJ8%xVOy^EV'PQEQESյ4-V2OoښM!JJ)k$٫H;qܞ:{;6.m۷;c7˙Fd=A~:S&]J]?*t鴣yѯ]Iٶn#F6΃q8žO+fm5纗/QŔ =һk-Z^ݞ3N7 qSVsL6&Z[~IuĤ]p#Q2[w8uU?{u*QqB{^)rw= ƝR;؏T0񞄒=+ <=|G$4׮oOAfX-DiӆB"[J4ގmEbsZQVu+,`nm|>=q[U83Hԏ2 (NԿ2[i~kOŚiLPf!/NJb@87sX>H_9jmUCuF}bAlg" A8ﶪ+[U8ُ)}'pe eA,#LןT6OݏdS\{1zvQ4b=BFL~c_<9P1w<@w895ICK*{-f(f!>].+[QAS:,U k{#Sl|?S~xz~F>ƪI_N(N2QQIߎ8۟ן־!:Am1ob7>?O54)p]C0Ȯ#S<'(bS8lc pOM'Ecszb^>1hVL'zvsyr( pȬ aQ= tB1qv8kTf-h_Ord# \ j֋KF^)IݼJ[l͑'#k3o/o5wKּg! `IX{v.Q5&oWm'/F\㞙py?](Kray؜8ہ0=-V CaGw+7O⢗TQq6]~R;@G|rW(;sU!jMǺ!?cN:f<3cfMVy!JB8_Y03*1A`O8`t4:-.!C~dz4dP3M;_v4QErS]E*F4(G_·>^rꇷ><¸<7qf{[㷷x1(FZؚ!hW;HfK NE$k,֧˜9۔nF?JVCEZj YE+5jݬ*/o", ?K CީSW"us^Bs.H韽t 3%\qƺPmJ;e8#ӂWXjdjGQEbuQ@U=[SM"ݥnq\$=۲{~&2I_0?nób zc1ڸ#yfO,`2oXx1t(}NJ<ǝԜi^4ki[l7)"gVC^{xxu8YJP~+ա=Tp9g5iJW4biթ;uJ[JAw5%s:[SgQWT)W—/7sЫiڡE*c=%AOI#Ұڮ7rHIzpvVn>ʫUJ"F8h)+մMvV/55hRF\󋋳;TH *K K %~Yd VbHO ^$w?ZT:GWg$|*`ۈBMj⵼leX쭒znSCW}!ѸS쁐*k  }dU0o^`?+H*N.5&5.}emK^! ӑǥpZeߕ28g_wK-w.du~ \mpg >zpGZFSiƤ)FM[5(˱%3`9lRŷn@v񑟻Nt+IHfp8sW[Gg0T`W) Yӥ:-.!C~dzElcdQE!Q@Q@ι}X0s^ '||{]G?VW.6c~m֮'Yu*L߉?J֭ں3P5cP`N=((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCRTso cVaViPΏP+3P((((VCE!=jݢҡEVfEPEP$$Ifl!vh5@ 5#v@ #v:V l t65@ 5/ 22 sasytELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmAdobedC   ""  "'''''",////,7;;;7;;;;;;;;;;C ""2(!(2;2222;;;;;;;;;;;;;;;;;@@@@@;@@@@@@@@@@@@@@@@@@@@@`" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?Z(1 ( ( ( ( )L^FUQ՘S\i; Aǘ,9 x9Oc*I{eUԭmؤĬ::^xZf'2~UqWEHOX~~)R tR+q`>T7R g*ϴτ'i㹑ƣ)&wq=gE%t˧QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQ\'u[ucyT XC;ҝ77c*ݝ./[~Nap=85X..H^,(j tm,{~畈YQ1Q\ [w, r.t]m!+UV(@((((((((((((((kWRYYM4JK*wCzjW0qI8 QulF-QV=RV(d(YUHN%dtp)QEQEQEQEQEQEQEQEQEQEVv~r7c`H|.d)EJi3MGN6t[kY [ f>_'qo +/Q^ S/QEvW[4'>PGt)ҕG|D(;$XIu$XX"]BI'5Z 7slcf${ f@?3[<=8rmizEyQ<;"Yb.ˍrdS*ǯ*<-<ݻsv9۞qZ\F8٢J(:(((((((+|{ܽˤJ .~mݳ~EiJ+kh*+}H]TVV'"<|?gxkR:h) * B(((((( (1 ( ( ( (^#b89c dqWv_:ׅ/WKuD?;:vGQpQDX*qQaiy5 )hH((M2ۣH YQҹ;6qk##ӟNSέxR^}?)*0ZwJ LSʴxi,“}NފjfHIᕸe]ZiuFJJ(:rFl`=ŗ:[`8nW r}*NR爄&gUEsz c[8En~f#YUE֮8yΦ:= 4;H5 H#gR[?uv1ƲA(nkJ*,(4 +Լikh S1Ѱs {$7J %S}3ҵ 6;+w2I}>6Qqvxvl7Jc1։ДRӪ5袲GA#'dm9 횴WwKEbPK称3aI3fӱJN|Oo7rǰQqvgL*FjaEQ/L0ng3Gcx{Sj^DRWhl=N4r'^ݝ=.tEWu?9l_x#_NzA=rSx%ܢ"mUr֫˗SN(¼ſ-z-y׋)?@Zgc%t~?)]s?)]g[f_+/X2d@wOEjQQ8Y3VhCOLpáó)kǙ@ʩMYh;s6ZGH|:]r;<_ GEDGCʷ~7.9V'.t{%orK=+e'V!crNӗejScެV5?T^l}rOnҚjVc( `[qHvBY =zYkL_.3W'ps8|oaL'et/cNCBqW,e*lQEU-WWLO' 7+̙đ˰>)J{ӤާoEy2ԡl m5h'X>TG(3%ךs8KN6wxX 2pb@;t ˣ[ *~e,p8/b=kAeΥx -ܟJ#NRxBj/vuTW7 F1(峄V;|߇kojR1ePT\1j㇜cACШCOӴnP26{%zWmsk,LXdQ:r洫¯(@SV-¾{qs9?X3Pp\g9ʮO,+XМzPv-o}Q" AVaN]&[}c ^vNr[?ϯ։ќGKJzQEdnV4BA;T ꀹ^Ww&9L?L}unqk G8I5^cxIKh" [%8VT+PUfҳܺԹc#dQK1QҸN- d|ҜcOkt=؊t~&wWxTI1a֮C\`]fUT0YEgݶ~SV ׷+vgdd+mmJ` Χ ڋ#v=1p쉩VtW\TnƎ,g;_3S|Ah# c#wkoTʳ*-S(wVjAW L?6 ;ӭo \xfHV2`rGv>+fZΣ}YGEձUܫ`g˃zU"kGݜ句tTT+=FpEp#r:Ub~z/WkE<%dHu8sgS5m7327?8R#{KqIgFQvIe `㦯,eFz++C;d ~j:8]=+'^%I+@; v5;}>G8_^Os< ݽ8oTcTSXgԭ'Sl䪌AqgMpDBBpPMXJwtQEdtQEhbQEQEQElC1Q\ڶ;p?CZ"92(x" }U+/I\[BJ?((E*AAk.}!!󓞟wTu nL ʻ)G:gߊl+|˨Pvfkx4`eQp zuϧ_h+2,Of\)"dVS qT_Bqqܫֱ"F@ zEyzZ@];/8o#:/\]S@`X"S磩4/s+yg'w;>ֺuK1I$;yki噋1,rzVxh)J KI#NWu3{vZ]?q-sǓѥ :(8(gTUphҊR+8.Dc8ޡL,441ۦ->b7W3Th6bB9cA\&x#vl;{q涼{uK'qڿ꧆u]%VR0JQR9U(Ӻݞn"qQQYir췍P~y={5 &SVYRJ{YX9y|X:oqֲi7O6X` z&kZ$(cNpqg=&r_r f.0=r޼\90P4[ ן]=dg W$;@?]K[ǜ,|ņxU:nf#R#9# ?"+klDQˁ4)p$Ue=U`{5ãIwiP0I0oO㷪Z,!#s!I5)эH;yzyzmrek-\ k3$`WxAs?5JEX  a/C %6*:=O\׎?:.efbAy~y\x]Az|"캜 ҟ=O9G\5P7.e#Dxlv5חjnmۃ9qpe4tS]uɹbQ.9n ֻK {J5KdӠ.Yw;}V*Vi>~ZjDă(N89>,Z6ܬogu^\- (x>OUԬge5|5^3dC 6=뚱^>iAU7ʧs\n-PM:5%m~3zSV <0%VaUEB`; l3%‡e!S둷(;7_OחWu\dMyuuvg|H )x'Ev,NApf$oC5y)ڻ6ہn1zWh4d|q>?Ķ:UI66?t iV/Rh4K;k#x펦QEstb (² )9,rBp+Vꖺp BOU.N0z˧rxaKu ߠzI#,E`>? {ن:9Ψ DN HpU)UN5\NQfzuw F=GF++t1"ŭ[' ?v)  ; cj8,oRwrʧr2K8yusQp=*A$N) u%y&OOʜB~W_Gc2+Դ;x!#z7vqq1&Ҭ\-Nǫ4jqR+5+@Vi`^^ABl"WxKJ'c,ѫ1ðEmåY8+xFXXgVwmm?caVOxGEۢ$k*pXAǰ`8H >rsO ڬK:Ho:eܿN3m3p=Ad]Hm;bP\|3mFFp*s)$FDVسo+:ɻ2BDd$+g 0qՌq1Xi)OP}?R"F0Y+k)cdSn2cT Ys>F:A'q޸ -\d</~۪Mܱ5>a}W[+%Dvbqsߡ?_hnU Le'8.~czg..#^{g8<{V+m"4ٴ[-\d+=Fkg% \p$ d?7Bj-Ew='" z%yOE\Cz̿^m/jWm\Oo|_RjOYxx35]y3Z[c[A aP7g`z.뼿BLjL $a+)+vi5`A:c'5 [j6o9l@? p+{#.?(s}UoVK-ā@#<ɟ):)S,Su*C<-c5AdqܼA5SƮ<=&F#T<^>Kn"pr2 z'/CwC^6_I R:2?Ey! O+;>*Il=~(8kQGNkQGNkQGNkQGNkW?u3 'Y09*ztlSdeR+# U 2*U _ߦ zg5^Zt~U%ܩ91v<`W_kky/mFaq[ݹxkt):r꼵Q\W=[ _ʝE -Ue$&G7Ldp}{SV I=ks,אDOʱnf E vF@$ 8Ȯ~2+~bmgN21n{56Xctk !Fڬj 鳖Ȧ% #?sFs|RM薇׵ykW׶VއS_4Q\MCPbƟ1+?Zx1U#0x=w_ʏ-?*usױCP|X~_^i޺/BEwQF'?#<DdIS+k+ǵ^Mnsr$PqS ]˕CV0AG\5,yяzI\= UH)!Zt~TykS:`c ?¾-^iEeT SOk|C+ 6}@bxWM:ڠ$Ht"pqћ?E?Eu4W79oWzO"_ h^gf nzaGkQJU%fʆu0f4}W|/ WxA?F%yއ! O+ &yه~_Zt~TykSkQGNkWLZWWxB?Et7pf^t6.@?o+c%u53|b7_ʏ-?*uSkm"#-Å߯i67QWf`wLtb|ă-/pw,y6[UKYdnA*䐊:5/Em*̼VY>⑟y]ugM-?*ψ`.?pעםD_7p:/~odgWԮTKy*S\o|_R~ LiT E:E N<$-A;0 m/AF=/ttDxϘPrN=Y\o:nxDxjg zydsou;Xmlr9j+ؖhX:8"r2ʑtzZt~UG\E}D5\ߍy :VӔG]yg׵ykW׶WN7axi,D=-?_D.JB/ Ua?#]_ʝEpr._`W跮'=r o]g|-?*{i)e8=+keHV?:pB*0r6) ]@ӭ o20yU-?*|Ÿx2F'P޺¬\f׆$-?*~!K f2@V2+4v*Oqr(oƨ1ݳŅz_q҉57~99b >ƻ:1RAeh=L[zm0aA۰xu]'P2@8\>Tӯ8li[JSǴRJKcJQٗ_QѵuT@C/p=Q5 F0'k|7<ٹ6ۻ +89JwKttz(%#^?w\% y /5{WZt~T+c i}2A˃ӡ3qZLJ42 r8UլW43(tq tR;: u֌ x%[{!Ac9oEbҼϱQݝ۶9Z\i_BǖZt~T+c+:hvm8E,HTp\d5~ m%LtDαGH/k3슚@- w!5ErRry8q*tiɋӱIG_5Ϥ?¯U]SPM.["nW+9AQN;+;^>Ӂ. :A/W^7G|r">^:sA_אтXfOj_ʝEpaxi,D=-?_D.JB/ WvL33|Ťb #^^U=Jp܉ʧd$#VsX^1}ENiQo^[Z5hI y=y=+zqGfjtC|~ǁNzO7?$AzcZSu s(k7P#?o +(?*߇7b,!EW9S^Ee dr~'uQEyȴ@ *Ȃ@`&IRq]ë֖{s"p$nTƹj 8N>BH+wgZM9 mcY]a˶Y^AB-~6Q >tcbAG5/}OB_-z۬/ȯp@=8?kN7//6RBd}>tG׽p:F?nnN^Gc?3zzY bNAcᴊ Hq]twGnyŨ?l|38 rqs񩵝+KXU"5VcPM?M&E1(i+3;J:oDB_W+]D;!o^^wBް̿^m/jWm\Oo|_RjOYxx35]y3^[Oz.뼿D_-z YľEW '^>E A/Wv7G|r8;L  ȫ J-l2ZIv?L#]]4[Ol%Ur?3#AS8gScePC+A ЃN1Oi21cl2I'9? ֣-`ب|3sWqrs?_N{N, T n-|;۠E޿yZk@T էhҖ1<[6lV<؉)8Nv:%ϛQЕea:yZj]FuN#rt,N K.81 lL)&Ǫ[`\m]؇s31xkLRk_0o֝#!,%YW]l?zA~*qJUP`:)WجT/w{4Eщ^wB r2sxk:Z¬Dj#WPV'*TعEW9r?w__zˋHo$Ѥ@u 3QCY8+xFXXgWD+qW)S-V'4jTJu;g8ֶc'tuTǏMk{ 8,Lï^ƺ?q`O r6-~a(h#C 5s}.nX3۟ƺ"p ZOs9{ȷ:{3ll+\XapQu=FZeKX'?:}ƴ*Thڍ|ӝʥVFA"^֒+K8r~p=1cNTҬ 18XZgxPGa:|g'ן|⵿dӟEuO\-%ķS ު*í?]+WVq9CHCΧvU!'>Xv+ ύ$˹Cma\b;-mygb:gԌecF;K'?slbWbnh#C 5^=&)A]*jXRObQ\hQEWxB?EzUJs$;ѫ1HhUTsu࢟Sϼ; vf ~ΡF1V,sȿ ?"IԶXZ$c̃rµZwg=<>. %5o.<}Π'rҲC\G$Hʎ#qשåY8+xFXXgU&1b7ON- eEȍ+sJ)FA^wB޽\ih#."ENW#A֧ʙ|6e+4-e~3 >w qv(Lp*z*T2 =%:%ϕ.QІVS:,"agYksһHo$Ѥ@u 3Yx_KFmc%s6T~xM{ )~VG&Ņ+"u!cej[+-s\l(G :*r^!O\GNM/hr~^6\G zAsco{φ96>31:ZJ%\rgR %SlP~XV !o9'<L k{-D1ǻء3*[2 t1N2dx$ښh+,#r.kS^^EZB K) ) ׮ƽR#*1W{$k*pXA̹w}cc]?X׿Ui?JާUEXcld)%-O\\9$aHz}zWZVEL6 `L}='QV\er+[XXaP ]ztn$p E}y[VvvNkjj&ɔ01Ԃ~z<̠Clκ7g,To鏽קS:U[e$yWGq8zq7!mxRp?+Ӵ!4KDycHsd nN8EE@U砩*+WuF\:넿!j5J8  PESNuM= `^I^Zy"DLWr9@确$k*pXAʔ%vtW*v8Ko ϷccQ|mw"12qʖ{k w{w1l>^5%t yVтpf7>H[V: sK#YT U?=?} IWTX4QEs'?slbWbnh#C 5^=&)AtRqbprUI=_&]d&6d3 a SGc][$S:>Ww4ܡTWSXSz˛:U×keuWKSp,jOsFZ~kq4h΢1G<3vx^-mygb:gqi ℚ4A}pi,B\ȧsÿK\CJJoٱx`6#*zd YVJFO+3s\=qC UXGys4F @ F905ZM`AtV8:ьy\nqԜ;X(h `d0 O #'^C9~{c5I&F,mI$G>6ZVv$$aі5VjfJzyH7Zʭa }zWA [FF0Tu¨RQYU*S ^Hڊ̒(pHFL'<`1zT:rX 9YTh,n*~V݌|uj|="lI v\u5zš]{T |~HTU]ȩ4d o鏽קkV)SSis{wt-Ǜ%2~?yzgڼDb::y^Uo4MC>|+s(ٺQr.V{IsG1amI%3?V|kp], xy9 iU-c ӡք~%?uGOH?\5B @*[ʅr@NSfS؏y%Q7w95Tѯ*~pgeNv$1rF=ԩ9q _Ĭ-` ;~lh2w$ԒORN*qJUP`:+GGSեSCfxDɑKg%yIz~\&"7cǦ15ңBK{x7:{i+G$g'\"/x]z\ (~DٛmyLlS&}s3~Cf g8NQZvgRB\3<91q=vq{]W=Jr;QT`(5 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ()L(A ǫb,<ap1:-NF"58Բ s]f{ ˢ *ڗk9qXR;4t1t]ÂT k+WՕ2:N@>XaYw9k OWI+KGl]p䑏Qq;;Bur1uqsVPkW_,ҷOj-K];qe'?x>=Fxl`ۦrաQ^>cL&Rw (;((((;o6Wd`BDVM pǯtD)SA*y#W-sG8?@1i{=y|O6-K])dq'j B'x|jҰ9.~?-LL()q)OgC~cŽ959s\]͗Ԟ`WmyltO$gӽ[%M4b0qzڢt`AEW1ٗFDd H0  # ARFLuW]EgFELuW]JFIF" XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmAdobedC     $''''$25552;;;;;;;;;;C  %%#(((((#,0000,7;;;7;;;;;;;;;;`" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?Z(1 ( ( ( ( +䷚[ 0m& );QC\:ֺX[o#d s|to;kMEy1)ԗ?G[p5Yi>lWh'iKH\ gEۺzUWK{4w0.Y^UVv;"}QEQEQEQEQEQEQEQEWMBap!e< ߑV^^X#Etv$: s,\]oeEQEQEQEQEQEQEQEQEQEQEQE#F$fcMs~8!޶rˍZ6q[v|gX-/˃Cco|3,-m5ʙ (>ㆦ&JʊZo&i[ѷ}H[,/ӣEfRJ23$~Fgn27ѻ}y~YTtݹ]tPUV (6 )M fibq܅Qkռm;CqQ\W rFU‚ߢʫͩig)UaMyî{OFfHûA a}־uSt[]AsmtKYRdih82ԕ7]N@߼J̗WPjcWtW2O7cj3ަtbb)NϡQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEKZ:~svDÿȇ ®~h5ռySzȐ(qU s+tM[K~WoS,w|g.qǭz%aTv+nbȡ01^6n<2;]8 _kOEW!W)xQ5I젎-KX=jQխ1ױxW{ThbwDX~C%Y~cUWy4+i$bVfcIBI&w@# ϭki,t8젎-KzUJ7RJ:M;uzh~,u=R )c~Tf˟J&;x^yR' $W,sҥZ >JFsr6!͟Z96ƊA֋ Q^2ю4Wxܩ*괭^Xh8x ׵DN hiKJ^(6 +Z=gn.p Hs#nڼ;eݕ*o8R_rV9WJiWGrŗkm* mQ|[KM(3@<~U#%Bq ZZB'fx6?:վڃ$@[#CV>]iKwh]x 򬧪 S ٜquIFnzWMӮ$3Ok67;Ƭ$H`,S!3߯Z\ŵ=R)$Gꨑꗑơ.%UU`/ iuƇm4K#yVc +?/}_2m]ׄ_2JڧUn )ךim/tyZtIC2<AlR$eYx_EwrsO-j"$hơUUU-C[4oNb;:gV>d" 6x F]T.GmzjRֿMQ땕]\qxX s>~Z|qwjqګ[hW|ǜs\a4۞.I|̭6ZV\V`ugoz?D4_bgIzg`V[\w9P9q]U^"rODeUtF1+2O v 㱯?t;Gfrܡ*@ zEs~;D:\(lr#)aԔz>ьҏSE^^u/-+_'.$p:?slSe嫞ckIc:o_E^^u.o&ُ516v.];T;?@ӬtVP*~rH,q4 RD IK6t+F1k]L]{Ö[D] F<ާ\ ͳXvX.?/}_2mZaxQaN0q}M."ȡ03UI4:[ubSR7 1ϩjWy4 Fv,@u9]G+Ƿ`L#lWo:VqN*޲9[gQUf28's*AL晦FfvA)e;:k%K{qx& 퀄~5֘Dp4SݛԊK4gXgdǞ_hm\-ś0ܫ2F2ޅIǨ?@fPJIދ+:3q]MtcRoz* _רחh5Q1_} 2߂~(;¸ROtUÏ;n>y:O M4vĥݰNFI)i.&y;` ]h^NOØUpdžT y|m/Ac~|WobHPcPQ鶿a!CCulYըICB4`ejuD'`,hY>ioun߈? "R$WnɌZ6 Gr/[F&Exl?E2RͦYVcErVLXUkw/]eR>m#5^e$#GҴ.M.I,&fhJ)$:?,/kQs.tvpo-3KE{Ihm۟2Fvzyk+K,d J)Kc[ ֔?ڡ;y~eC;0;D| !yٿ8F_yQXaEP:$ȡVV ][ 1n'|^g'?t֭Q53LVT'CL }NT\EEOIMGN.$hơUUW3Y}ndWL\cnsNVB gc9P2zմEndhت@pT2Zڝ*{|Z=H8ͣ2odm -xYpz6^^G^On3f dxEg#;Gxb0*-~ґ$,CD2. ^ڛ~o2wx–[%ޥ@G ;c}ҍչ#ֺ GuL "Z7vFR,R_?SOzgٮh9AN29>]BFiUDЩUA}j玿|-sw]~U$V#c}y,>1(֟=$ڶ ˌ;|6u=kwHѤ"pI'i.&y;` Yᠥ&7t9FLJ<8uc%όg8A$oep" \w`}솝[}\n&TU޾DkFVڲ+;Kj9go\nҙaY鐘,f.Ws7@V(koY_S?]F=$Gp]q5hl knLGS涼{ulڭ3;moΪxg]ӴXgJN˟,)P߼s9QpHq\Jݩ,:3+ G,ܒ71gjM%*˰J(#k#?:?vNs|}[οo/n}k>lX-~Sqd`DԿد*YB~zI[kZ$B2$voVv l@{@T޼\)5# 5O(AZXE{K5yks`E Д!qJcA/԰^N v7O^;,Lz-O뎶=]Zrǝ2 j kmd5-ԄFqJZSo[.e-:QWJRQEQEQEQEQEQEQEQEQEQE{ˏyqt~BEgsk \QE|?!GG)Qp.?Q u\,7ˏyqt~BMDYX" ,$ <?!Nqt~B]#`1`o_ogzy=B+B Zn~ns޺0ݝTVgB)o ! PRtZꫀW6;b^r7 Ӫ :XtR6:q hL|Kf_%zG+<#-RW?,2_]jT]% [GpG_mT"jO-^m1aYsv\/ķ tQשWxF[eQњ?_:XG3.?W1@踫^?S.?WkkZ7j sCZ}M|R9s_gx1j̕W3&M^@ck`,!`+_VFT{ij2spAfqe$]jnx(uKFuVQWk h\\qa,UX =Fz8IQer<KYuHʊX7yqt~B\$)Ƭ#5.?WąCF2yaIivH#K+D9$ڼkķP1{t iأ|,FyEʥD̪F4\zͯS_իI]]8z)#]G+ZC]ʛd};b<Ա.jM 04(A=߽'^O%Gzyz ]?ak]߆>U( <?!Nnz q`n!ZȳUeF$i*4RtpUA=7 )vdUPiX_æk61#9]Le .?WkD&% KDI N:W_uip# 㩮L=UHy}_c)P~U <?!Nz <?!Nv eO\\ >y:`}{W~ ~͙gJF99c:4[[vb =yDDXa * @wCT+)?r.Wya} ό̤1R@$c-H]YѴbGKiYa@ABf\Z kJ \¹9kV;J*RcW^ Z>ǔw0f<5xBuXt>u<F-z'?Z_6:CZ}C zȌc3|?!GG)W ^+ UtXJ?ғr/l\'`r/lG}*zf}QTU\bw!l,@Bq?4d%H58)|QMbz~DűeeAvyqt~BkIia+ٍ{C ӞW,')TXFk <?!N< B?뤴 WN4.&h F$n~jqٻ,ݛb=@;'uxI;IDc#\vwFR~CȜ!kUU>kWz/T»S>r_u}ƫOE݆}ۻ*ٻڋ֢NJMNJQMu3A(Y6#^? ׬-k_gyqt~B.?Sqt~B.?Sa\ˏ(XoG(:. <?!Nqt~B.?Sa\ˏ(XoG(:. <?!Nqt~B.?Sa\ˏ(X((((+ {%2%ˬM,rH@I.*.Y'kّR̭SʴzZP!o\m<8V?'X\X$sx²HG^eW3E}qg7|9q+K%ldF1FZ?GiNkԎCRzmS-. 0u9PGQ|;󉂺#\.r~GCѭ ;v?^y\QZ9|%*\[O,E9$Y>՚(VwgzJ)$ŨkD Dnc\(a=sYUހƓHcF+۷*8rN5qO]8[ԁc݉g Dy9*Fv8**ɻL/+a$4jS5?t,U/c\p0Ojѵ#C6 mݜu9ԩ[1)tw- \[F@?4r/q?{o;(23LaTҴC&)ا s¿{o qXٕ|Ӟz]t^K99aQiJ㬬5ޥ֦y!@R\{eQk~ci{Nt\+NךR^mm䵺K kt#} >8$XP*;SmE3uLKnsd>eFY"#h1L|a$ȓl9pQ0U9+jVs+Mqgo4$Hp02YI+bEH^.j;<$6?%0ߍÏzf]o/#ED$hcX$?.5PK i kQMr_Qmm4!nT (_Fy[q"E|/%)ԫQԚVW9gmT5-LF0%C# 9*ȯBn=5" 4?C"jO-^m1at;484k+-c~7Hvf]:>ݵpr'+]zחxF[eQiZ]̭5ŝ67<#1e'URWƘ;A4+E]MEoikf+Hc V% OxnGi (WaZ:'0Xl]=!Y5߉\|FY$+)i}w)¯']u[ۨyD$T7˵._yo %; r#7'㇞N>GƧCԼkX+2eG*I]2v8=2) h <]MÇ"6 sM3/$]#Fža-]^(Uh'yHbU-N؋š!4̜(VW$ܞi4QE"((() 6 R>9[o:yc!h0Wtl2qg:VͿt 2E} vVzvsֱ铒IhI)I5qQWS9ڢ^?i8>:E_@7"% >ūϵr]7lk cS{0+qtMq>xX1빚. t hSDg9\m#h +}t(k"*SNO2Vy{˫a[!c]-W4I= TF QRXQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEٳ$$If!vh5 5#v #v:V lQ t0~~~~~~'5 52s2hgfyt2$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt2$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/$$If!vh5 5#v #v:V l t0~~~~~~'5 52s2hgfyt/DyK Thttp://www.npaihb.org/programs/project/nwtccp_reports_publications_media_materials/yK http://www.npaihb.org/programs/project/nwtccp_reports_publications_media_materials/yX;H,]ą'cUDyK 2http://cancer.gov/cancertopics/pdq/adulttreatmentyK |http://cancer.gov/cancertopics/pdq/adulttreatmentyX;H,]ą'cDyK ?http://www.cancer.gov/cancertopics/factsheet/Detection/stagingyK http://www.cancer.gov/cancertopics/factsheet/Detection/stagingyX;H,]ą'cuDyK :http://www.cancer.gov/cancertopics/factsheet/detection/CTyK http://www.cancer.gov/cancertopics/factsheet/detection/CTyX;H,]ą'cDyK Ihttp://www.cancer.gov/cancertopics/factsheet/detection/pathology-reportsyK http://www.cancer.gov/cancertopics/factsheet/detection/pathology-reportsyX;H,]ą'cDyK Chttp://www.cancer.gov/cancertopics/factsheet/Detection/tumor-gradeyK http://www.cancer.gov/cancertopics/factsheet/Detection/tumor-gradeyX;H,]ą'cDyK Ehttp://www.cancer.gov/cancertopics/factsheet/detection/tumor-markersyK http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markersyX;H,]ą'cDyK >http://www.cancer.gov/cancertopics/understandingcancer/canceryK http://www.cancer.gov/cancertopics/understandingcancer/canceryX;H,]ą'c5DyK *http://www.cancer.gov/cancertopics/wyntk/yK lhttp://www.cancer.gov/cancertopics/wyntk/yX;H,]ą'cDyK Ehttp://www.cancer.gov/cancertopics/factsheet/detection/tumor-markersyK http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markersyX;H,]ą'cDyK Hhttp://www.cancer.gov/cancertopics/factsheet/detection/laboratory-testsyK http://www.cancer.gov/cancertopics/factsheet/detection/laboratory-testsyX;H,]ą'cDyK Chttp://www.cancer.gov/cancertopics/factsheet/detection/tumor-gradeyK http://www.cancer.gov/cancertopics/factsheet/detection/tumor-gradeyX;H,]ą'cDyK ?http://www.cancer.gov/cancertopics/factsheet/Detection/stagingyK http://www.cancer.gov/cancertopics/factsheet/Detection/stagingyX;H,]ą'cDyK yK Fhttp://www.cancer.gov/yX;H,]ą'c/@@@ ImNormalCJ_HaJmH sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No List4 @4 ImFooter  !.)@. Im Page Number4@4 ImHeader  !dO"d ImDefault1$7$8$H$-B*CJOJQJ^J_HaJmH phsH tH 6O!"6 ImCM1d  B*^Jph2O!"2 ImCM11 B*^Jph2O!"2 ImCM12 B*^Jph2O!"2 ImCM13 B*^Jph2O!"2 ImCM15 B*^Jph2!"2 ImCM18 B*^Jph2O!"2 ImCM19 B*^Jph2O!"2 ImCM16 B*^JphHH Im Balloon TextCJOJQJ^JaJ2O!"2 0CM27 B*^Jph2!"2 0CM28 B*^Jph2!"2 0CM20 B*^Jph>*@> 0Endnote ReferenceH*<+@< #0 Endnote Text CJaJ2!"2 0CM21! B*^Jph6U@!6 0 Hyperlink >*B*ph<1< 0 Char Char_HmH sH tH B'AB 0Comment ReferenceCJaJ<R< 0 Comment Text%CJaJ8!"8 tCM10&d B*^Jph>@r> t Footnote Text'CJaJ@&@ tFootnote ReferenceH*6!"6 >>@3ABDEEF)H4H6H7H9H:H>>@3ABDEEF)H4HoHpHzH{H|HHHHyIzI{J|JaK@LAL_M`MaMiM0000 0 0 00 0 0 0 0 00 0 0 0 0 0000000  000  0 0 0 00 00000 0 0000 0 0 0000 0 0 0000 000000 0000 00 @0@0@0@0 @0 @0@0@0 @0 @0@0@0 @0 @0@0@0@0@0@0@0@0@0@00000000 0 0 0 0 0 00000000000000 0 0 000000000000000-0-000000.0,0,0-0 0 0 0-00K000000D0$00"00$00$00$00&00&00&00(000<00<0000000(00(00(00*0+00AX0*00.000<00<0200070070200070.0020 020 020 040 040 040 00 00$00$00!00!00!00 00 00 00  00  00  00 00000<0 00 0<0 004 00  00  004 00  00  004 000@0@0@0@0@00000000000000H0p +@0`@0`005000000@0`0 0\ @0 @0 @0 @0 @0 @0 00 @00000B=, =H[[[^ n LC= #$(*/24`689z<?BFJNrP1QSThU+/135>?DGHIJLMNOQRTVZ^cgmnpqrtuv 2 +II$b"+45a66y829s99::;y<~==S>^?2@A8BB3IPhU,.0246789:;<=@ABCEFKPSUWXY[\]_`abdefhijklosgU-<|<<P>>>??@@@0A3BBBCCDDDBE)FvFFGG&HhMXXXXXXXXX=DHOQ^!!NJ9 nXXXXv(XP@AR$㛚y*ىfO fVR$Y;c-2t^ߛfR$u3AR$M1z][fR$=\RI3q;fRռhR$wܕ@≞qPR$%0|e5kwlZR$7G(}lV'R$K5 q`8R$D1,d$ /*R$&=JDEٞ[St0R$<"cH9h+1n@@h(   8 C FA . ]];T`T;T`T]"` 9 C FA . ]];T`T;T`T]"` : C FA . ]];T`T;T`T]"` ; C FA . ]];T`T;T`T]"` > C FA . ]];T`T;T`T]"`t @ s *@~8c"` B S  ?:$' &:hM8-@9h|)@:h0*@;*@>Th0*@@p) t(`6|:iM:iM9*urn:schemas-microsoft-com:office:smarttagsplace  l{66 77<<<<<<P>>>>>>?@@@@@@1A3A6A7A8A3BBBBBBCDDDDDDCEEEHEIEJEFF4H4H6H6H7H7H9H:HF   W : A %)>IBoq+-ru$0qySKMMO ' G T :!C!!!""B#T#$%%%&''"'~''''+(3(((*#*,-7-B--_...//!0,0;1r1~11#2*222233x444b5{5667(777R889999Y::;+;<<<>'>P>>>?@@@@@1A2AAA3BBB8C~CCDDDCEDEEEEF4H4H6H6H7H7H9H:H>>?@@@@1A2A3A3BBBBCDDDDCEDEEEG3H4H4H6H6H7H7H9H:H>?@@1A3BBCDDCE4H4H6H6H7H7H9H:H%F%`%&N&"~&C'kH''=(,)`U)c*&+=+E+( -[ ---_-Y.\./6K/DR/0.0M0b1[M2Q2;3s4-4@4bR4055>.555D5g5k5D~5V%6q6t6q7wS7 8'8U89d87.9u9h:;h;';X(;b<=_=k=>u*>p>l? @jAZA B)BLB}BjCPCYC9ZChCE4EaEQF*{F{F$GVG_HiJc J)J8JVvJ1K%K[o"[.[r@[[[)[[b[>[,\a\i\}o\ ]+]YR]j]w(^A^&_~<_o_`b`\e`o`o`~aa[abAHbQcd d9;d|_ddfd6|d($eobeiDfNfF)gr}g~gh;h3@hKJh[hD/i jjj;j>j6>j~j2GkU_k:}kl9lm5mm mImNxm| n>oBo$so pXpdpzqeqrr#r:rCr,sAsk^s`s9{st!t8tstuD@uNuPuhus vv1w1w\w_wvwi8x.FxHx+y.DyMOy)zf+zwkzuzxz1{B{}D{:_{uc{=k{Z|9|w[|l|;~=~&i~um~=CL$E 3Jn"$(Q|^i+ 3 b3<S3( @HN({*WQ(8-9>@lV_s )[Pr9K$!awk!_#2`N^mL&3\BU2la j#\ I6G,RT A*:=M/;UW970={SlMAlnJC`ikx3ECJ 'M)~a_/cH Wbty J5WeMi9yeA.!57NA:#/Q0?HTf[dk'm} <CQ|>sEhIE`U-9;mL'E"%1I'LMMafIz-B)1F`/i=`9mu4 4%@)/8>CCQfm.UU2 Ec1bk8 ,?.Xk +@A uv1OnP )LNEo;'4TAU$BRMH\^&1. s? LM) 5G//>QHQ51R\`xTSnxy=Os' ? 14T?mA~, t0[ghsyw7Qt T-4YK *FN>\U6)'He<]IfvX3^@L7s[y O<DU{gzd{$c$34:.B! !df!x;lg ,-CcMIxfp.http://www.cancer.gov/cancertopics/understandingcancer/cancer]YEhttp://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers33Chttp://www.cancer.gov/cancertopics/factsheet/Detection/tumor-gradeCE Ihttp://www.cancer.gov/cancertopics/factsheet/detection/pathology-reportsX :http://www.cancer.gov/cancertopics/factsheet/detection/CTo'?http://www.cancer.gov/cancertopics/factsheet/Detection/staging Y2http://cancer.gov/cancertopics/pdq/adulttreatment/2Thttp://www.npaihb.org/programs/project/nwtccp_reports_publications_media_materials/o' ?http://www.cancer.gov/cancertopics/factsheet/Detection/staging33Chttp://www.cancer.gov/cancertopics/factsheet/detection/tumor-gradel}Hhttp://www.cancer.gov/cancertopics/factsheet/detection/laboratory-tests]YEhttp://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers1-http://www.cancer.gov/  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`acdefghijklmnopqrstuvwxyz{|}~Root Entry F@BfData 1TablebWordDocumentSummaryInformation(DocumentSummaryInformation8CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q